Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate
Marga Nijenhuis, Bianca Soree, Wafa O. M. Jama, Nienke J. de Boer‐Veger, Anne M. Buunk, Henk‐Jan Guchelaar, Elisa J. F. Houwink, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan J. Touw, Jan van der Weide, Roos van Westrhenen, Vera H.M. Deneer, Arne Risselada
Topics & Concepts
CYP2D6AtomoxetinePharmacogeneticsMethylphenidatePharmacogenomicsPharmacologyGuidelineAtomoxetine hydrochlorideMedicineBiologyGeneticsGenotypeAttention deficit hyperactivity disorderGeneClinical psychologyPathologyPharmacogenetics and Drug MetabolismPharmaceutical studies and practices